Investors

Shareholder Information

Incanthera plc's shares are traded on the Access Segment of AQSE Exchange Growth Market, Updated as of 4 April 2025.

Symbol: INC

ISIN GB00BGL7YW15
LEI code 2138002HEV4UFBOEXQ97

There are no restrictions on the transfer of AQSE Securities.

The main country of operation is United Kingdom. Incorporated and registered in England and Wales with registered number 11026926.

Incanthera plc is subject to the City Code on Takeovers and Mergers.

Shareholder Analysis

No. of shares in issue:
121,366,645
Warrants outstanding: 12,860,878
Options outstanding: 9,175,000
Fully diluted:
143,402,523
Percentage of Shares in public hands: 60.28%
Percentage of Shares not in public hands: 39.72%

Major Shareholdings

Shareholder Number of shares held % of issued share capital

Tyndall Investment Management

21,707,597

17.89%

NWF (Biomedical) LP

16,164,540

13.32%

University of Bradford

13,408,007

11.05%

Unicorn Asset Management

13,065,834

10.77%

Mr Tim McCarthy

3,931,646

3.24%

Dr. Simon Ward

3,064,199

2.52%

Contact:

Head of Communications & Company Secretary
Suzanne Brocks
Suzanne.brocks@incanthera.com